Published in Cancer Weekly, September 28th, 2004
This technology upgrade was fully implemented as of mid-August 2004. The company expects this upgrade to positively impact earnings in third and fourth quarters of 2004.
Fuzhi Song, chairman and CEO of Genex, commented, "We are delighted as we continue to experience strong customer acceptance of our products. We expect the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.